Volitionrx (VNRX) Beginning Cash Balance (2019 - 2020)
Volitionrx (VNRX) posted Beginning Cash Balance of $17.0 million for Q1 2020, up 26.36% on a QoQ basis from $13.4 million in Q1 2019, and up 26.36% year-over-year from $13.4 million in Q2 2019.
Volitionrx (VNRX) Beginning Cash Balance (2019 - 2020) Analysis & Trends
Volitionrx's Beginning Cash Balance history runs 2 years deep, the most recent figure standing at $17.0 million for Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 16.97 Mn |
| Mar 31, 2020 | 16.97 Mn |
| Mar 31, 2019 | 13.43 Mn |
| Mar 31, 2019 | 13.43 Mn |